Irritable bladder syndrome in an animal model: a continuous monitoring study.
Irritable bladder syndrome (IBS) was induced in four female African green monkeys (Cercopithecus aethiops) by the use of intravesical instillation of acetone. The animals were housed in a modified metabolic cage for continuous micturition monitoring, and two uroflowmeters connected to a remote PC monitored the frequency, voided volumes, and peak flows. Before and after, urea absorption studies and urodynamics were obtained for each animal. Urea absorption increased significantly after acetone instillation and returned to baseline after 4 weeks (26 to 66 to 32%). Intravesical acetone instillation produced marked effects on bladder physiology in the first week. Bladder compliance dropped from a baseline of 10.47 to 0.58 ml/cm H2O. The voiding pattern changed from a normal pattern with a mean voided volume of 17.58 ml into marked increase in frequency and dribbling pattern with few voids (mean = 5.03 ml). Systematic behavioral observations were carried out for 4 hours per day utilizing an observation program on a laptop computer. Activity patterns, attention, sterotypic behaviors, and self-directed activities were recorded for each monkey. The animals demonstrated decreased frequency of activity and increased frequency in self-directed activities (groom, scratch), behaviors consistent with an animal experiencing pain or discomfort. The findings suggested that IBS induction in monkeys is feasible and produces a clinical picture similar to interstitial cystitis in humans. It offers a suitable animal model to enhance the understanding of voiding dysfunction with its neural pathways and to test the different therapeutic modalities to control IBS.
Ghoniem
G M
GM
Department of Urology, Tulane Regional Primate Research Center, Covington, Louisiana.
Shaaban
A M
AM
Clarke
M R
MR
D000096:Acetone / Q000008:administration & dosage; D000818:Animals; D002522:Chlorocebus aethiops; D004195:Disease Models, Animal; D004576:Electromyography; D005260:Female; D007322:Instillation, Drug; D008991:Monitoring, Physiologic; D009043:Motor Activity; D018482:Muscle, Skeletal / Q000503:physiopathology; D009130:Muscle, Smooth / Q000503:physiopathology; D013577:Syndrome; D014508:Urea / Q000378:metabolism; D001745:Urinary Bladder Diseases / Q000503:physiopathology*; D014555:Urination Disorders / Q000503:physiopathology*; D014563:Urodynamics
D000096:Acetone; D014508:Urea